Metastasized cancer means cancer that has spread from where it originally started to a different part of the body. If breast cancer cells travel to the liver, for example, that liver tumor is still breast cancer, not liver cancer. This distinction matters because treatment targets the original cancer type, not the organ where it landed. In the medical staging system, any cancer that has spread to a distant site is classified as M1, which generally places it at stage IV.
How Cancer Spreads Through the Body
Metastasis isn’t a single event. It’s a chain of steps that cancer cells must complete, and most cells that attempt it fail along the way. The process starts when cells from the original tumor break free and push into the surrounding tissue. From there, they enter either blood vessels or lymphatic channels, which are the body’s two main transportation networks.
Lymphatic vessels are often the easier route. Their walls are leakier than blood vessel walls, with looser junctions and fewer surrounding support cells, so tumor cells face less resistance getting in. But both pathways eventually connect: lymphatic fluid drains into veins near the collarbones, so cells that enter the lymphatic system can still end up in the bloodstream.
Once in circulation, cancer cells have to survive the physical shear forces of blood flow and evade the immune system. The vast majority don’t make it. Those that do must then exit the bloodstream at a distant site, settle into new tissue, and begin growing. This final step, colonization, is the hardest. A tumor cell can lie dormant in a new organ for months or years before it establishes a blood supply and grows into a detectable mass.
Where Different Cancers Typically Spread
Cancer doesn’t spread randomly. Each type tends to favor certain organs. Breast cancer most commonly spreads to the bones, brain, liver, and lungs. Colon cancer typically goes to the liver and lungs first. Lung cancer favors the adrenal glands, bones, brain, liver, and the opposite lung. Prostate cancer frequently reaches the bones, adrenal glands, liver, and lungs. Bladder cancer follows a similar pattern: bone, liver, and lung.
These preferences are partly explained by blood flow patterns (the liver filters blood from the digestive tract, making it a common landing spot for colon cancer) and partly by the chemical environment of the destination organ. Some tissues provide growth signals that certain cancer types can exploit, while others are inhospitable.
How It’s Named
Metastatic cancer keeps the name of its origin. Breast cancer that spreads to the bone is called “metastatic breast cancer” or “breast cancer with bone metastasis,” never bone cancer. Under a microscope, the cells in the bone still look like breast cancer cells, and they carry the same genetic mutations. This is why treatment follows the playbook for the original cancer type rather than the organ where the metastasis appears.
You may also hear it called “secondary cancer” or “stage IV cancer.” These terms all refer to the same thing: cancer that has traveled beyond its original location to a distant site.
Symptoms Depend on Where It Spreads
Metastatic cancer can cause very different symptoms depending on which organ is affected. Bone metastases often cause deep, persistent pain that worsens over time, and bones weakened by cancer can fracture more easily. Liver metastases may cause jaundice (yellowing of the skin and eyes), abdominal swelling, or nausea. Lung metastases can lead to shortness of breath, a persistent cough, or chest pain. Brain metastases may cause headaches, seizures, vision changes, or difficulty with balance and coordination.
Some people with metastatic cancer have no symptoms at all, especially early on. The spread is sometimes discovered incidentally during imaging done for another reason, or through routine follow-up scans after treatment for an earlier-stage cancer.
How Metastatic Cancer Is Found
Detecting metastases usually requires imaging. CT scans and MRI both produce detailed three-dimensional views of the body’s interior, with MRI often being more sensitive for soft tissue differences. PET scans, which detect areas of unusually high metabolic activity, are frequently combined with CT scans to better distinguish cancerous tissue from normal tissue. Bone scans are commonly used when bone metastases are suspected.
Because metastatic deposits can be tiny and located deep within the body, doctors often use a combination of these tools. A biopsy of the suspected metastasis may also be taken to confirm the cells match the original cancer.
Why Treatment Shifts to Systemic Therapy
When cancer is confined to one area, surgery or radiation can often remove or destroy it entirely. Once it has metastasized, the approach changes. Because cancer cells have proven they can travel through the bloodstream, there’s a reasonable chance they’ve reached places that don’t yet show up on scans. Treatments that circulate through the entire body, like chemotherapy, immunotherapy, and targeted therapy, become the standard approach. Surgery and radiation still play a role, but typically for symptom relief: shrinking a tumor that’s pressing on a nerve, stabilizing a weakened bone, or reducing pain.
The goal of treatment also shifts in many cases. For localized cancer, the aim is usually cure. For widespread metastatic cancer, treatment often focuses on controlling growth, maintaining quality of life, and extending survival as long as possible.
Oligometastatic Disease: A Middle Ground
Not all metastatic cancer is the same. In the mid-1990s, researchers proposed that some patients fall into an intermediate state between localized cancer and widespread metastatic disease. This is now called oligometastatic disease, meaning cancer that has spread to only a small number of sites.
This distinction has real treatment implications. When there are just a few metastatic spots, aggressive local treatment of those spots (with surgery or precisely targeted radiation) combined with systemic therapy can sometimes produce long-term remission. Clinical trials have shown meaningful improvements in both progression-free survival and overall survival when local treatment is added for oligometastatic patients, compared to systemic therapy alone. In some cases of newly diagnosed oligometastatic disease, the intent of treatment is cure rather than just control.
The concept is still evolving, but it has already changed how oncologists approach patients who have limited spread. Rather than treating all metastatic cancer as one category, doctors now assess how many sites are involved, where they are, and whether aggressive local treatment could make a difference.